Recall: D-0660-2024

Class II - Potentially Harmful

Class IIClassification

2024-08-30Initiated

CompletedStatus

Glenmark Pharmaceuticals Inc.,Firm

Product

Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, 07430, NDC 68462-180-22.

Reason

Subpotent Drug

Distribution

Product was distributed nationwide within the United States.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.